About Intas

Recruitment Fraud Disclaimer:

Intas Pharmaceuticals does not request or accept any fees during recruitment. If someone asks for payment on our behalf, it is a scam. Please report the incident to the local police or cybercrime unit. Your trust and safety are important to us.

Intas is a leading global pharmaceutical company specializing in the development, manufacturing, and marketing of pharmaceutical formulations. The mission of the company is to address unmet medical and societal needs through a fully integrated pharmaceutical value chain spanning across the world.

Through its subsidiaries, the International presence of Intas includes the following countries: over 85 worldwide, with some of the more important global markets like North America, Europe, Latin America, and the Asia-Pacific under the well-known brand name Accord Healthcare. The rapid expansion has been due to organic growth and strategic acquisitions alone, vindicating its position in some of the important major pharmaceutical markets across the world.

Intas follows high standards of quality, as reflected by products approved for leading global regulatory agencies including USFDA, MHRA, and EMA. Substantial in-house R&D capability, along with the beginning of a focus on highly advanced areas like Biosimilars and New Chemical Entities-Intas continues to push the frontiers of excellence in healthcare.

At Intas, our success is fundamentally built on the strength of our people. Our ongoing commitment is to attract and retain the best talent in the industry while fostering an empowering environment that encourages innovation and excellence. This approach ensures that every employee plays a meaningful role in driving both the company’s growth and advancements in global healthcare.

Job Title:  Manager - Purchase

Job Requisitions No.:  13864
Job Description: 

Purpose of Job

To lead and manage the procurement function for the Biosimilars Manufacturing facility at Intas Pharmaceuticals. This role is pivotal in ensuring the timely and cost-effective acquisition of raw materials, equipment, and services essential for the production of high-quality biosimilars, while maintaining compliance with regulatory standards and company policies.

Roles and Responsibilites

  • Strategic Procurement Planning: Develop and implement procurement strategies aligned with the biosimilars manufacturing objectives, ensuring a consistent supply of quality materials and services.

  • Supplier Management: Identify, evaluate, and establish relationships with reliable suppliers. Negotiate contracts and terms to secure favorable conditions for the company.

  • Inventory Management: Oversee inventory levels to prevent shortages or overstock situations. Implement just-in-time procurement practices to optimize storage costs.

  • Compliance and Documentation: Ensure all procurement activities comply with Good Manufacturing Practices (GMP), regulatory requirements, and internal policies. Maintain accurate records and documentation for audits and inspections.

  • Cross-Functional Collaboration: Work closely with R&D, Quality Assurance, Production, and Finance departments to forecast material requirements and align procurement activities with production schedules.

  • Cost Management: Monitor and control procurement budgets. Implement cost-saving initiatives without compromising on quality.

  • Risk Management: Assess and mitigate risks related to supply chain disruptions, supplier performance, and regulatory changes.

  • Team Leadership: Lead and mentor the procurement team, fostering a culture of continuous improvement and professional development.

Location: 

Biotech, Ahmedabad, GJ, IN, 382213

Travel:  0%

Life at Intas Pharmaceuticals

For over three decades, Intas has thrived due to the exceptional talent of its people. Our growth is fueled by a dynamic environment that nurtures individual potential while fostering collaboration and collective success. We believe that when diverse skills and perspectives unite under a shared purpose and value system, we can achieve remarkable outcomes, driving innovation and excellence across the pharmaceutical landscape.

Date:  26 May 2025